EXCHANGE AGREEMENT
This EXCHANGE AGREEMENT (the “
Agreement ”), dated as of May ___, 2009, is by and
among NutraCea, a California corporation with offices located at
5090 N. 40th Street, Suite 400, Phoenix, Arizona 85018 (the “
Company ”), and _______________ (the “
Holder ”).
RECITALS
A. The
Company, the Holder and various others entered into that certain
Securities Purchase Agreement, dated as October 16, 2008 (as
amended and modified by this Agreement and the Other Exchange
Agreements (as defined below), the “ Purchase
Agreement ”).
B.Simultaneously with the consummation of the
transactions contemplated by the Purchase Agreement, the Company
issued and sold to the Holder pursuant to the Registration
Statement (as defined in the Purchase Agreement) (i) 3,000 shares
of Series D Convertible Preferred Stock (the “ Series D
Preferred Stock ”) and (ii) a Series A Warrant (as
defined in the Purchase Agreement) initially exercisable for
2,727,273 shares of Common Stock (as defined
below).
C. Since
the issuance of the Series D Preferred Stock, one or more
Triggering Events (as defined in the Certificate of Determination,
Preferences and Rights of Series D Convertible Preferred Stock) may
have occurred thereunder.
D. The
Company has authorized a series of preferred stock entitled the
“Series E Convertible Preferred Stock” (the “
Preferred Stock ”), which Preferred Stock shall be
convertible into shares of the Company’s common stock, no par
value per share (the “ Common Stock ”), in
accordance with the terms of the Preferred Stock. The
rights, preferences and other terms and provisions of the Preferred
Stock are set forth in the Certificate of Determination,
Preferences and Rights of Series E Convertible Preferred Stock in
the form attached hereto as Exhibit A (the “
Certificate of Determination ”). As used herein, the
term “ Conversion Shares ” shall include all
shares of Common Stock issuable upon conversion of, or as dividends
on, the Preferred Stock in accordance with the Certificate of
Determination.
E. In
exchange for all of the Holder’s shares of Series D Preferred
Stock, the Company has authorized the issuance to the Holder of
_____ shares of Preferred Stock.
F. In
exchange for the Holder’s Series A Warrant, the Company has
authorized the issuance to the Holder of a warrant, in the form
attached hereto as Exhibit B (including all warrants
issued in exchange therefor or replacement thereof, the “
Warrant ”), which Warrant shall initially be
exercisable for __________ shares of Common Stock (as exercised,
the “ Warrant Shares ”), in accordance with the
terms thereof.
G. The
Preferred Stock, the Conversion Shares, the Warrant and the Warrant
Shares are collectively referred to herein as the “
Securities .”
H. The
exchange of the Holder’s Series D Preferred Stock and Series
A Warrant for the Preferred Stock and the Warrant will be made in
reliance upon the exemption from registration provided by
Section 3(a)(9) of the Securities Act of 1933, as amended (the
“ 1933 Act ”).
AGREEMENT
NOW, THEREFORE, in consideration of the premises
and the mutual covenants contained herein and for other good and
valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the Company and the Holder hereby agree as
follows:
|
|
EXCHANGE OF
SERIES D PREFERRED STOCK AND SERIES A WARRANT.
|
(a)
Series D Preferred Stock and Series A Warrant . Subject to
the satisfaction (or waiver) of the conditions set forth in
Sections 6 and 7 below, the Company shall, pursuant to Section
3(a)(9) of the 1933 Act, exchange (i) all of the Holder’s
shares of Series D Preferred Stock for ____ shares of Preferred
Stock and (ii) the Holder’s Series A Warrant for the
Warrant.
(b)
Closing . The closing (the “ Closing ”)
of the exchange of the Holder’s Series D Preferred Stock and
the Holder’s Series A Warrant shall occur at the offices of
Greenberg Traurig, LLP, 77 W. Wacker Drive, Suite 3100, Chicago,
Illinois 60601. The date and time of the Closing (the “
Closing Date ”) shall be 10:00 a.m., New York time, on
the first (1 st )
Business Day on which the conditions to the Closing set forth in
Sections 6 and 7 below are satisfied or waived (or such later date
as is mutually agreed to by the Company and the Holder). As used
herein “ Business Day ” means any day other than
a Saturday, Sunday or other day on which commercial banks in New
York, New York are authorized or required by law to remain
closed.
(c)
Delivery . On the Closing Date, (i) the Holder shall deliver
all of its shares of Series D Preferred Stock and its Series A
Warrant to the Company and (ii) the Company shall exchange,
issue and deliver to the Holder (A) _______ shares of Preferred
Stock for such shares of Series D Preferred Stock and (B) the
Warrant for such Series A Warrant, in all cases duly executed on
behalf of the Company and registered in the name of the
Holder.
|
|
HOLDER’S REPRESENTATIONS AND
WARRANTIES.
|
Holder represents and warrants to the Company
that:
(a)
Organization; Authority . The Holder is an entity duly
organized, validly existing and in good standing under the laws of
the jurisdiction of its organization with the requisite power and
authority to enter into and to consummate the transactions
contemplated by the Exchange Documents (as defined below) to which
it is a party and otherwise to carry out its obligations hereunder
and thereunder.
(b)
Validity; Enforcement . This Agreement has been duly and
validly authorized, executed and delivered on behalf of the Holder
and constitutes the legal, valid and binding obligations of the
Holder enforceable against the Holder in accordance with their
respective terms, except as such enforceability may be limited by
general principles of equity or to applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation and other
similar laws relating to, or affecting generally, the enforcement
of applicable creditors’ rights and remedies.
(c)
No Conflicts . The execution, delivery and performance by
the Holder of this Agreement and the consummation by the Holder of
the transactions contemplated hereby and thereby will not (i)
result in a violation of the organizational documents of the Holder
or (ii) conflict with, or constitute a default (or an event which
with notice or lapse of time or both would become a default) under,
or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, indenture or
instrument to which the Holder is a party, or (iii) result in a
violation of any law, rule, regulation, order,
judgment or decree (including federal and state
securities laws) applicable to the Holder, except in the case of
clauses (ii) and (iii) above, for such conflicts, defaults, rights
or violations which would not, individually or in the aggregate,
reasonably be expected to have a material adverse effect on the
ability of the Holder to perform its obligations
hereunder.
(d)
Residency . The Holder is a resident of that jurisdiction
specified below its address on the Schedule of Buyers attached to
the Purchase Agreement.
(e)
Own Account . The Holder is acquiring the Securities as
principal for its own account and not with a view to or for
distributing or reselling such Securities or any part thereof in
violation of the 1933 Act or any applicable state securities law,
has no present intention of distributing any of such Securities in
violation of the 1933 Act or any applicable state securities law,
and has no direct or indirect arrangement or understandings with
any other persons to distribute or regarding the distribution of
such Securities in violation of the 1933 Act or any applicable
state securities law (this representation and warranty shall not
limit the Holder’s right to sell the Securities in compliance
with applicable federal and state securities laws); provided
, however , that by making the representations herein, the
Holder does not agree, or make any representation or warranty, to
hold any of the Securities for any minimum or other specific term
and reserves the right to dispose of the Securities at any time in
compliance with applicable federal and state securities laws. The
Holder is acquiring the Securities hereunder in the ordinary course
of its business. The Holder shall notify the Company in writing of
any transfers by the Holder of any of the Preferred Stock or the
Warrant and such notification shall contain the name and address of
the transferee.
(f)
Experience of the Holder . The Holder, either alone or
together with its advisors and representatives, has such knowledge,
sophistication and experience in business and financial matters so
as to be capable of evaluating the merits and risks of the
prospective acquisition of the Securities, and has so evaluated the
merits and risks of such acquisition. The Holder is able to bear
the economic risk of an acquisition of the Securities and, at the
present time, is able to afford a complete loss of such
acquisition. The representations contained in this Section 2(f),
however, shall not modify, amend or affect the Holder’s right
to rely on the Company’s representations and warranties
contained herein or any representations and warranties contained in
any other Exchange Document or any other document or instrument
executed and/or delivered in connection with this Agreement or the
consummation of the transaction contemplated hereby.
(g)
Holder Status . At the time the Holder was offered the
Securities, it met, and as of the date hereof it meets, the
definition of “institutional investor,”
“accredited investor” or other similar term forth on
Exhibit 2(g) that is applicable to it based on the
state in which the Holder is located. The Holder is not required to
be registered as a broker-dealer under Section 15 of the 1934
Act.
(h)
Ownership . The Holder does not as of the date hereof, and
will not immediately following the Closing, own 10% or more of the
Company’s issued and outstanding shares of Common Stock
(calculated based on the assumption that all Equivalents (as
defined in the Purchase Agreement) owned by the Holder, whether or
not presently exercisable or convertible, have been fully exercised
or converted (as the case may be) but taking into account any
limitations on exercise or conversion (including
“blockers”) contained therein).
|
|
REPRESENTATIONS AND WARRANTIES OF THE
COMPANY.
|
The Company represents and warrants to the
Holder that:
(a)
Organization and Qualification; Subsidiaries . Each of the
Company and each of its “ Subsidiaries ” (which
for purposes of this Agreement means any Person in which the
Company, directly or indirectly, owns capital stock or holds an
equity or similar interest) are entities duly organized and validly
existing and in good standing under the laws of the jurisdiction in
which they are formed, and have the requisite power and
authorization to own their properties and to carry on their
business as now being conducted and as presently proposed to be
conducted. Each of the Company and its Subsidiaries is duly
qualified as a foreign entity to do business and is in good
standing in every jurisdiction in which its ownership of property
or the nature of the business conducted by it makes such
qualification necessary, except to the extent that the failure to
be so qualified or be in good standing would not have a Material
Adverse Effect. As used in this Agreement, “ Material
Adverse Effect ” means any material adverse effect on (i)
the business, properties, assets, liabilities, operations
(including results thereof), condition (financial or otherwise) or
prospects of the Company or any of its Subsidiaries, taken as a
whole, (ii) the legality, validity or enforceability of the
transactions contemplated hereby or in the other Exchange Documents
or (iii) the authority or ability of the Company to perform any of
its obligations under any of the Exchange Documents. Other than the
Subsidiaries, there is no Person in which the Company, directly or
indirectly, owns capital stock or holds an equity or similar
interest. Except as set forth in Section 3(a) of the
disclosure letter delivered by the Company to the Holder
concurrently with the execution of this Agreement (the “
Disclosure Letter ”), the Company has no
Subsidiaries.
(b)
Authorization; Enforcement; Validity . The Company has the
requisite power and authority to enter into and, except as set
forth in Section 3(b) of the Disclosure Letter, perform its
obligations under this Agreement and the other Exchange Documents
and to issue the Securities in accordance with the terms hereof and
thereof. The execution and delivery of this Agreement and the other
Exchange Documents by the Company, and the consummation by the
Company of the transactions contemplated hereby and thereby
(including, without limitation, the issuance of the Preferred Stock
and the reservation for issuance and issuance of the Conversion
Shares issuable upon conversion of, or as dividends on, the
Preferred Stock, the issuance of the Warrant and the reservation
for issuance and issuance of the Warrant Shares issuable upon
exercise of the Warrant) have been duly authorized by the
Company’s board of directors and no further filing, consent
or authorization is required by the Company, its board of directors
or its stockholders or other governing body or regulatory
authority. This Agreement and the other Exchange Documents to which
the Company is a party have been (or upon delivery will have been)
duly executed and delivered by the Company and when delivered in
accordance with the terms hereof and thereof, will constitute the
legal, valid and binding obligations of the Company, enforceable
against the Company in accordance with their respective terms,
except as such enforceability may be limited by general principles
of equity or applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation or similar laws relating to, or affecting
generally, the enforcement of applicable creditors’ rights
and remedies and except as rights to indemnification and to
contribution may be limited by federal or state securities law.
“ Exchange Documents ” means, collectively, this
Agreement, the Warrant, the Certificate of Determination, the
Irrevocable Transfer Agent Instructions (as defined below) and each
of the other agreements and instruments entered into by the parties
hereto in connection with the transactions contemplated hereby and
thereby. Except as set forth in Section 3(b) of the Disclosure
Letter, the Company has no reason to believe that it will be unable
to comply with any of its obligations under any of the Exchange
Documents (including, without limitation, as a result of
application of Section 500 or Section 501 of the California
Corporations Code).
(c)
Issuance of Securities . The issuance of the Preferred Stock
and the Warrant is duly authorized and, when issued in accordance
with the terms of the Exchange Documents, shall be validly issued,
fully paid and non-assessable and free from all taxes, liens,
charges and other encumbrances imposed by the Company. As of the
Closing, the Company shall have reserved from its duly authorized
capital stock not less than 133% of the sum of (i) the maximum
number of Conversion Shares issuable upon conversion of the
Preferred Stock (assuming for purposes hereof that the Preferred
Stock is convertible at the initial Conversion Price (as defined in
the Certificate of Determination) and without taking into account
any limitations on the conversion of the Preferred Stock set forth
in the Certificate of Determination) and (ii) the maximum number of
Warrant Shares issuable upon exercise of the Warrant (without
regard to any limitations on the exercise of the Warrant set forth
therein). Upon (i) conversion of the Preferred Stock in accordance
with the Certificate of Determination, (ii) issuance as dividends
on the Preferred Stock in accordance with the Certificate of
Determination or (iii) exercise of the Warrant in accordance with
the Warrant (as the case may be), the Conversion Shares and the
Warrant Shares, as applicable, when issued, will be validly issued,
fully paid and non-assessable and free from all preemptive or
similar rights, taxes, liens, charges and other encumbrances
imposed by the Company, with the holders being entitled to all
rights accorded to a holder of Common Stock. The offer, exchange
and issuance of the Securities is exempt from registration under
the 1933 Act pursuant to the exemption provided by Section 3(a)(9)
thereof. Upon issuance in accordance with the terms of
the Exchange Documents, the Securities will be freely tradable
without restriction. Notwithstanding the preceding
sentence, the Warrant Shares will be freely tradable without
restriction so long as such Warrant Shares are exercised pursuant
to a cashless exercise as provided in the Warrant.
(d)
No Conflicts . Except as set forth in Section 3(d) of the
Disclosure Letter, the execution, delivery and performance of the
Exchange Documents by the Company and the consummation by the
Company of the transactions contemplated hereby and thereby
(including, without limitation, the issuance of the Preferred
Stock, the Warrant, the Conversion Shares and Warrant Shares and
the reservation for issuance of the Conversion Shares and Warrant
Shares) will not (i) result in a violation of the Articles of
Incorporation (as defined below) or other organizational documents
of the Company or any of its Subsidiaries or Bylaws (as defined
below) of the Company, (ii) conflict with, or constitute a default
(or an event which with notice or lapse of time or both would
become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation of, any
agreement, indenture or instrument to which the Company or any of
its Subsidiaries is a party, or (iii) subject to the making of the
Required Filings (as defined below) by the Company, result in a
violation of any law, rule, regulation, order, judgment or decree
(including foreign, federal and state securities laws and
regulations and the rules and regulations of the OTC Bulletin Board
(the “Principal Market ”)) applicable to the
Company or any of its Subsidiaries or by which any property or
asset of the Company or any of its Subsidiaries is bound or
affected except, in the case of clause (ii) or (iii) above, to the
extent such violations that could not reasonably be expected to
have a Material Adverse Effect.
(e)
Consents . The Company is not required to obtain
any consent, authorization or order of, or make any filing or
registration with, any court, governmental agency or any regulatory
or self-regulatory agency or any other Person (as defined below)
(including, without limitation, the Financial Industry Regulatory
Authority) in order for it to execute, deliver or perform any of
its obligations under or contemplated by the Exchange Documents, in
each case, in accordance with the terms hereof or thereof, other
than (i) the filing with the SEC of the 8-K Filing (as defined
below), (ii) such filings as are required to be made under
applicable state securities laws (clauses (i) and (ii) are
collectively referred to as the “ Required Filings
”) and (iii) as set forth in Section 3(e) of the Disclosure
Letter. All consents, authorizations, orders, filings and
registrations which the Company is required to obtain on or before
the Closing Date pursuant to the preceding sentence have been
obtained or effected on or prior to the Closing Date, and neither
the Company nor any of its Subsidiaries are aware of any facts or
circumstances which might prevent the Company from obtaining or
effecting any of the registration, application or filings pursuant
to the preceding sentence. Required Filings to be made after the
Closing Date shall be made in compliance with the terms of this
Agreement and applicable federal and state securities laws. Except
as set forth in Section 3(e) of the Disclosure Letter, the Company
is not in violation of the requirements of the Principal Market and
has no knowledge of any facts or circumstances which could
reasonably lead to delisting or suspension of the Common Stock in
the foreseeable future.
(f)
Acknowledgment Regarding Holder’s Exchange of
Securities . The Company acknowledges and agrees that the
Holder is acting solely in the capacity of an arm’s length
purchaser with respect to the Exchange Documents and the
transactions contemplated hereby and thereby and that the Holder is
not (i) an officer or director of the Company or any of its
Subsidiaries, (ii) an “affiliate” (as defined in Rule
144 promulgated under the 1933 Act) of the Company or any of its
Subsidiaries or (iii) to its knowledge, a “beneficial
owner” of more than 10% of the shares of Common Stock (as
defined for purposes of Rule 13d-3 of the Securities Exchange Act
of 1934, as amended (the “ 1934 Act ”)). The
Company further acknowledges that the Holder is not acting as a
financial advisor or fiduciary of the Company or any of its
Subsidiaries (or in any similar capacity) with respect to the
Exchange Documents and the transactions contemplated hereby and
thereby, and any advice given by the Holder or any of its
representatives or agents in connection with the Exchange Documents
and the transactions contemplated hereby and thereby is merely
incidental to the Holder’s acquisition of the Securities. The
Company further represents to the Holder that the Company’s
decision to enter into the Exchange Documents has been based solely
on the independent evaluation by the Company and its
representatives.
(g)
Placement Agent’s Fees . Neither the Company nor any
of its Subsidiaries has engaged any placement agent or other agent
in connection with the transactions contemplated by this Agreement.
The Company shall be responsible for the payment of any placement
agent’s fees, financial advisory fees or broker’s
commissions owed to any Person pursuant to any other agreements
entered into by the Company relating to or arising out of the
transactions contemplated hereby. The Holder shall have no
obligation with respect to any fees or with respect to any claims
(other than such fees or commissions owed by the Holder pursuant to
agreements entered into by the Holder, which fees or commissions
shall be the sole responsibility of the Holder) made by or on
behalf of other Persons for fees or the type contemplated in this
Section that may be due in connection with the transactions
contemplated by the Exchange Documents.
(h)
No Integrated Offering . None of the Company, the
Subsidiaries or any of their affiliates, nor any Person acting on
their behalf has, directly or indirectly, made any offers or sales
of any security or solicited any offers to buy any security, under
circumstances that would cause this offering of the Securities
(together with any other offering pursuant to the Other Exchange
Agreements) to require approval of stockholders of the Company
under any applicable stockholder approval provisions, including,
without limitation, under the rules and regulations of any exchange
or automated quotation system on which any of the securities of the
Company are listed or designated. None of the Company, its
Subsidiaries, their affiliates nor any Person acting on their
behalf will take any action or steps referred to in the preceding
sentence that would cause the offering of any of the Securities to
be integrated with other offerings.
(i)
Dilutive Effect . The Company understands and acknowledges
that the number of Conversion Shares and Warrant Shares will
increase in certain circumstances. The Company further acknowledges
that its obligation to issue the Conversion Shares upon conversion
of the Preferred Stock and the Warrant Shares upon exercise of the
Warrant in accordance with this Agreement, the Certificate of
Determination and the Warrant is absolute and unconditional
regardless of the dilutive effect that such issuance may have on
the ownership interests of other stockholders of the
Company.
(j)
Application of Takeover Protections; Rights Agreement . The
Company and its board of directors have taken all necessary action,
if any, in order to render inapplicable any control share
acquisition, business combination, poison pill (including any
distribution under a rights agreement) or other similar
anti-takeover provision under the Articles of Incorporation or
other organizational documents or the laws of the jurisdiction of
its incorporation or otherwise which is or could become applicable
to the Holder as a result of the transactions contemplated by this
Agreement, including, without limitation, the Company’s
issuance of the Securities and the Holder’s ownership of the
Securities. The Company and its board of directors have taken all
necessary action, if any, in order to render inapplicable any
stockholder rights plan or similar arrangement relating to
accumulations of beneficial ownership of shares of Common Stock or
a change in control of the Company or any of its
Subsidiaries.
(k)
SEC Documents; Financial Statements . Except as set forth in
Section 3(k) of the Disclosure Letter, during the two (2) years
prior to the date hereof, the Company has timely filed all reports,
schedules, forms, statements and other documents required to be
filed by it with the SEC pursuant to the reporting requirements of
the 1934 Act (all of the foregoing filed prior to the date hereof
and all exhibits included therein and financial statements, notes
and schedules thereto and documents incorporated by reference
therein being referred to herein as the “ SEC
Documents ”). The Company has delivered to the Holder or
its representatives true, correct and complete copies of each of
the SEC Documents not available on the EDGAR system. Except as set
forth in Section 3(k) of the Disclosure Letter, as of their
respective dates, the SEC Documents complied in all material
respects with the requirements of the 1934 Act and the rules and
regulations of the SEC promulgated thereunder applicable to the SEC
Documents, and none of the SEC Documents, at the time they were
filed with the SEC, contained any untrue statement of a material
fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not
misleading. Except as set forth in Section 3(k) of the Disclosure
Letter, as of their respective dates, the financial statements of
the Company included in the SEC Documents complied as to form in
all material respects with applicable accounting requirements and
the published rules and regulations of the SEC with respect thereto
as in effect as of the time of filing. Except as set forth in
Section 3(k) of the Disclosure Letter, such financial statements
have been prepared in accordance with generally accepted accounting
principles, consistently applied, during the periods involved
(except (i) as may be otherwise indicated in such financial
statements or the notes thereto, or (ii) in the case of unaudited
interim statements, to the extent they may exclude footnotes or may
be condensed or summary statements) and fairly present in all
material respects the financial position of the Company as of the
dates thereof and the results of its operations and cash flows for
the periods then ended (subject, in the case of unaudited
statements, to normal year-end audit adjustments which will not be
material, either individually or in the aggregate). No other
information provided by or on behalf of the Company to the Holder
which is not included in the SEC Documents contains any untrue
statement of a material fact or omits to state any material fact
necessary in order to make the statements therein not misleading,
in the light of the circumstance under which they are or were
made.
(l)
Absence of Certain Changes . Since the date of the
Company’s most recent audited or reviewed financial
statements contained in the Form 10-K, except as disclosed in
subsequent SEC Documents filed prior to the date hereof, there has
been no material adverse change and no material adverse development
in the business, assets, liabilities, properties, operations
(including results thereof), condition (financial or otherwise) or
prospects of the Company or any of its
Subsidiaries. Since the date of the Company’s most
recent audited financial statements contained in the Form 10-K,
except as disclosed in a subsequent SEC Documents filed prior to
the date hereof, neither the Company nor any of its Subsidiaries
has (i) declared or paid any dividends other than by Subsidiaries
to the Company, (ii) sold any material assets, individually or in
the aggregate, outside of the ordinary course of business or (iii)
made any material capital expenditures, individually or in the
aggregate. Neither the Company nor any of its Subsidiaries has
taken any steps to seek protection pursuant to any law or statute
relating to bankruptcy, insolvency, reorganization, liquidation or
winding up, nor does the Company or any Subsidiary have any
knowledge or reason to believe that any of their respective
creditors intend to initiate involuntary bankruptcy proceedings or
any actual knowledge of any fact which would reasonably lead a
creditor to do so. The Company and its Subsidiaries, individually
and on a consolidated basis, are not as of the date hereof, and
after giving effect to the transactions contemplated hereby to
occur at the Closing, will not be Insolvent (as defined below). For
purposes of this Agreement, “ Insolvent ” means,
on a consolidated basis, (i) the present fair saleable value of the
Company’s and its Subsidiaries’ assets is less than the
amount required to pay the Company’s and its
Subsidiaries’ total Indebtedness (as defined below), (ii) the
Company and its Subsidiaries are unable to pay their debts and
liabilities, subordinated, contingent or otherwise, as such debts
and liabilities become absolute and matured or (iii) the Company
and its Subsidiaries intend to incur or believe that they will
incur debts that would be beyond their ability to pay as such debts
mature. Neither the Company nor any of its Subsidiaries has engaged
in business or in any transaction, and is not about to engage in
business or in any transaction, for which the Company’s or
such Subsidiary’s remaining assets constitute unreasonably
small capital. For purposes of this Agreement: (x) “
Indebtedness ” of any Person means, without
duplication (A) all indebtedness for borrowed money, (B) all
obligations issued, undertaken or assumed as the deferred purchase
pric

|